VEITH 2019 Archives

VEITH 2019 Editor's Pick Interviews Learning Areas Venous Events Editors Pick Venous Venous Interviews Latest news Venous Video Types

VeClose five-year data give confidence about long-term durability of VenaSeal treatment

Kathleen Gibson (Bellevue, USA) put the five-year data from the VeClose study, which looked at the treatment of patients with venous reflux in the great saphenous vein (GSV) with either the VenaSeal closure system (Medtronic) or radiofrequency...

VEITH 2019 Editor's Pick Interviews Editors Pick Homepage Learning Areas Venous Events Editors Pick Venous Venous Interviews Latest news Venous

VEITH 2019: Abre venous stent study baseline demographic data presented

Stephen Black (London, UK) talks to VEITHtv about how the dedicated venous open-cell nitinol Abre stent (Medtronic) compares with other venous nitinol stents available, noting that it is very easy to use, has good flexibility attributes and a “good...

VEITH 2019 Roundtables Editor's Pick Editors Pick Homepage Peripheral Roundtables Peripheral Editors Pick Peripheral Latest news Peripheral Events Video Types

VEITH 2019: Vessel preparation “is the key to success” when using drug-eluting technology

Larry Scher (New York, USA) interviews John Aruny (Orangeburg, USA) and Stephen Hohmann (Dallas, USA) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA) about the use of drug-eluting devices in contemporary...

VeClose five-year data give confidence about long-term durability of VenaSeal treatment

VEITH 2019: Abre venous stent study baseline demographic data presented

VEITH 2019: Vessel preparation “is the key to success” when using drug-eluting technology

VEITH 2019

VeClose five-year data give confidence about long-term durability of VenaSeal treatment

VEITH 2019: Abre venous stent study baseline demographic data presented

VEITH 2019: Vessel preparation “is the key to success” when using drug-eluting technology

Percutaneous AV fistulas “not actually sacrificing” options, but rather “expanding” them

VEITH 2019: The future of endovascular aneurysm sealing (EVAS)

VEITH 2019: Tackling dehydration has a “tremendous impact” when treating claudication patients

VEITH 2019: “It was like the wild west”: Hazim Safi takes a look back at his vascular training years

Combination of scaffold and drug in BTK intervention “without question” the right way forward

VEITH 2019: “Light at the end of the tunnel” following paclitaxel collaboration

VEITH 2019: Paclitaxel controversy propels innovation in endovascular BTK treatment

TCAR a “phenomenal alternative” to carotid endarterectomy for high-risk patients

TCAR “combines best of both worlds” but carotid endarterectomy “remains the gold standard”

Physicians “must weigh long-term outcomes” against “short-term benefits” for aortic repair devices

Shockwave IVL can aid in eliminating recoil and dissection during below-the-knee angioplasty

High-quality evidence from multiple sources “key” to holistic assessment of endograft performance

Trials needed to assess whether metformin impedes aneurysm progression in non-diabetic patients

IVL has “changed the dynamics” of facilitating EVAR & TEVAR in calcified iliac arteries

Innovation summit brings different specialties together to “learn more than they would otherwise”

LEOPARD trial three-year data provide head-to-head comparison of AFX2 with other endografts

VEITH 2019: Fiber Optic RealShape (FORS) technology could spark a new era in image-guided therapy

EVAR before, and EVAR after: VEITH TV looks back with the pioneers

Slow rebalancing, not “seismic overnight change” in practice expected after NICE AAA guidelines